SOX9 and Familial prostate cancer: The successful analysis of more than 7,500 prostate cancers did not—in a general survey on all tumors—reveal relevant associations of an increased SOX9 expression with unfavorable tumor phenotype or poor patient prognosis as suggested by earlier works [10,14,15,17].